Role of Circulating miRNAs as Biomarkers in Idiopathic Pulmonary Arterial Hypertension: Possible Relevance of miR-23a

Table 2

Differentially expressed miRNAs in IPAH patients compared to healthy volunteers (HV).

miRNA ID	Average intensity	Average intensity	Fold change
	(HV)	(IPAH)
miR-7-1	0.33	1.08	3.25
miR-204	0.78	0.17	−4.67
miR-138-1	1.78	0.50	−3.56
miR-520h	0.78	0.17	−4.67
miR-559	1.11	0.25	−4.44
miR-593	0.67	0.17	−4.00
miR-601	0.56	0.08	−6.67
miR-616	0.89	0.17	−5.33
miR-543	1.11	0.25	−4.44
miR-1184	0.33	1.67	5.00
miR-1285	1.89	6.00	3.18
miR-1286	0.11	0.58	5.25
miR-3153	0.78	0.17	−4.67
miR-3156	0.89	0.17	−5.33
miR-4301	0.78	0.25	−3.11
miR-4304	0.89	0.25	−3.56
miR-4313	1.22	0.33	−3.67
miR-1-2	0.11	0.92	8.25
miR-1259	0.67	0.17	−4.00
miR-1263	0.22	0.83	3.75
miR-193a	0.22	0.75	3.38
miR-195	0.22	0.75	3.38
miR-30c-2	0.67	0.08	−8.00
miR-3120	0.89	0.17	−5.33
miR-3145	0.67	0.17	−4.00
miR-3184	0.33	1.08	3.25
miR-340	0.56	0.08	−6.67
miR-4261	0.78	0.25	−3.11
miR-524	0.56	0.08	−6.67
miR-606	0.89	0.25	−3.56
miR-634	0.56	0.08	−6.67
miR-921	0.56	0.08	−6.67
miR-99a	0.67	0.08	−8.00
miR-181d	0.89	0.17	−5.33
miR-1893	0.89	0.25	−3.56
miR-1934	0.56	0.08	−6.67
miR-1944	0.33	1.08	3.25
miR-1957	0.11	0.83	7.50
miR-1981	0.11	0.75	6.75
miR-20a	0.25	0.79	3.15
miR-145	0.12	0.39	3.21
miR-27a	0.17	0.53	3.12
miR-328	0.89	0.28	−3.15
miR-23a	0.21	0.65	3.09
miR-2145-2	0.22	0.75	3.38
miR-23b	0.33	1.41	4.27
miR-291a	0.56	0.08	−6.67
miR-191	0.11	0.58	5.25
miR-327	0.11	0.58	5.25
miR-423	0.22	0.92	4.13
miR-465b-2	0.22	0.75	3.38
miR-719	0.89	0.25	−3.56
miR-130	0.11	0.83	7.50
miR-124-1	0.11	0.58	5.25
miR-184	0.78	0.25	−3.11
miR-199a	0.67	0.08	−8.00
miR-30e	0.67	0.17	−4.00
miR-330	0.67	0.08	−8.00
miR-362	0.78	0.25	−3.11
miR-513	0.56	0.08	−6.67
miR-666	0.11	0.67	6.00